McBath Lowers Health Care Costs for Georgia Families

Historic Inflation Reduction Act Already Reducing Health Care Costs

October 12, 2022

Marietta, GA — Today, Rep. Lucy McBath (D-GA) shared new data on the impact of the historic Inflation Reduction Act in lowering health care costs. In August, the Inflation Reduction Act passed and included McBath’s provision capping insulin at $35 per month for Medicare patients. It slashes costs for working families in Georgia’s Sixth District and across the state. The historic legislation also forces pharmaceutical companies to negotiate lower drug prices and cuts health insurance premiums for millions of Americans. 

“Health care costs have been far too high for far too long, and the reality that families must choose between putting food on the table and paying for their life-saving medication is simply cruel. The American people deserve access to quality, affordable care for their families,” said McBath. “With the Inflation Reduction Act, we are putting the needs of our communities, our families, and our future generations over special interests. I’m proud of the impacts we have already seen from this historic legislation, and we will keep fighting to defend the needs of the American people.”

According to Congress’ Joint Economic Committee, because of Rep. McBath’s support of the Inflation Reduction Act:

  • 658,000 people in McBath’s congressional district can get and keep free or low-cost health insurance plans
  • 60,000 in McBath’s congressional district are now able to access affordable health care coverage
  • 1,376,000 seniors across Georgia will soon pay less for their medications, including having their out-of-pocket costs capped and paying no more than $35 a month for insulin

This cost-reducing bill received no Republican votes in either the House or the Senate. Extreme House Republicans have also announced their plans to repeal the Inflation Reduction Act, threatening affordable health care for millions of Americans and raising seniors’ drug prices while handing a multibillion-dollar giveaway to Big Pharma.